SCHEMBL24246975

SCHEMBL24246975

COCCn1nc(C(C)C)ccc1=O

nearest known ligand 0.39

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ MPO P05164 1/20 0.39
▸ KDM4E B2RXH2 3/20 0.38
▸ MEN1 O00255 1/20 0.38
▸ KMT2A Q03164 1/20 0.38
▸ PDE4B Q07343 2/20 0.37
▸ PDE5A O76074 1/20 0.37
▸ PDE3A Q14432 1/20 0.37
▸ ALDH1A1 P00352 4/20 0.36
▸ POLB P06746 1/20 0.35
▸ MDM4 O15151 2/20 0.35
▸ MDM2 Q00987 2/20 0.35
▸ PTGS2 P35354 1/20 0.35
▸ HCAR3 P49019 1/20 0.34
▸ HSD17B10 Q99714 1/20 0.34
▸ CYP3A4 P08684 1/20 0.33
▸ CYP2C19 P33261 1/20 0.33
▸ PDE4A P27815 1/20 0.33
▸ PDE4C Q08493 1/20 0.33
▸ PDE4D Q08499 1/20 0.33
▸ TSHR P16473 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL25746400 0.79 MPO (0.41) MPOKDM4EMEN1KMT2APDE4B
SCHEMBL24076248 0.78 KDM4E (0.44) MPOKDM4EMEN1KMT2APDE4B
SCHEMBL31366245 0.78 MPO (0.40) MPOKDM4EMEN1KMT2APDE4B
SCHEMBL24076322 0.78 MPO (0.40) MPOKDM4EMEN1KMT2APDE4B
SCHEMBL24246974 0.77 HRH3 (0.37) KDM4EMEN1KMT2APDE4BPDE5A
Hydrochloric Acid SCHEMBL30168555 0.77 MPO (0.39) MPOKDM4EMEN1KMT2APDE4B
SCHEMBL24246976 0.77 ADRA1A (0.36) KDM4EALDH1A1POLBMDM4MDM2
SCHEMBL15133211 0.76 MPO (0.37) MPOKDM4EMEN1KMT2AALDH1A1
SCHEMBL24077090 0.75 MPO (0.38) MPOKDM4EMEN1KMT2APDE4B
SCHEMBL21093431 0.75 NR1H2 (0.40) KDM4EMEN1KMT2APDE4BPDE5A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11247990-B1 Bicyclic fused pyridine compounds as inhibitors of TAM kinases ARRAY BIOPHARMA INC (US) 2022-02-15 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-11247990-B1 Bicyclic fused pyridine compounds as inhibitors of TAM kinases MAP3K1, MAP3K3, MAP3K2 MPO 3880/4885KDM4E 1075/4885MEN1 1758/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback